Quinacrine-induced psychiatric disturbances

Area of Science:

• Neuropharmacology
• Toxicology
• Clinical Psychiatry

Background:

• Quinacrine is an antimalarial and anti-inflammatory drug with a history of use in various conditions.
• Neuropsychiatric disturbances are known potential adverse effects of quinacrine therapy.
• Understanding the full spectrum of these reactions is crucial for patient safety.

Observation:

• Three distinct patient cases illustrate the diverse clinical presentations of quinacrine-associated neuropsychiatric toxicity.
• Observed symptoms ranged from subtle behavioral changes (restlessness, insomnia, irritability) to severe manifestations (psychosis, seizures).
• The onset of these toxicities varied, occurring shortly after drug initiation or significantly after discontinuation.

Findings:

• Quinacrine-induced neuropsychiatric disturbances present a broad and variable clinical spectrum.
• Adverse reactions can manifest at different points in the treatment course, including post-treatment.
• The variability underscores the need for vigilant monitoring of patients on quinacrine.

Implications:

• Clinicians must be aware of the wide range of potential neuropsychiatric side effects associated with quinacrine.
• Recognition of these varied reactions is essential for timely diagnosis and management.
• This emphasizes the importance of considering quinacrine toxicity in patients presenting with unexplained neuropsychiatric symptoms.